Ignite Creation Date:
2025-12-24 @ 4:40 PM
Ignite Modification Date:
2026-02-23 @ 4:55 AM
Study NCT ID:
NCT03430466
Status:
TERMINATED
Last Update Posted:
2020-08-12
First Post:
2018-02-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Anti PD-L1 Antibody + Anti CTLA-4 Antibody in Combination With Hormone Therapy in Patients With Hormone Receptor Positive HER2-negative Recurrent or Metastatic Breast Cancer
Sponsor:
Kyoto Breast Cancer Research Network
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-22
Start Date Type:
ACTUAL
Primary Completion Date:
2018-01-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-07-31
Completion Date Type:
ACTUAL
First Submit Date:
2018-02-06
First Submit QC Date:
None
Study First Post Date:
2018-02-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-08-10
Last Update Post Date:
2020-08-12
Last Update Post Date Type:
ACTUAL